HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ye Guo Selected Research
Ye Guo Research Topics
Disease
22
Neoplasms (Cancer)
01/2022 - 01/2008
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
09/2021 - 10/2009
13
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
04/2022 - 09/2012
10
Lymphoma (Lymphomas)
07/2021 - 02/2007
10
Leukemia
02/2021 - 10/2009
8
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2022 - 07/2014
6
T-Cell Lymphoma (Lymphoma, T Cell)
07/2021 - 07/2006
6
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 10/2009
6
Aplastic Anemia (Anemia, Hypoplastic)
01/2021 - 02/2014
5
B-Cell Lymphoma (Lymphoma, B Cell)
04/2022 - 08/2015
5
Disease Progression
01/2022 - 01/2008
5
Infections
06/2021 - 06/2013
4
Squamous Cell Carcinoma of Head and Neck
10/2021 - 02/2011
4
Adenocarcinoma of Lung
01/2021 - 01/2019
4
Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2020 - 06/2015
4
Cardiotoxicity
03/2020 - 05/2016
4
Extranodal NK-T-Cell Lymphoma
01/2020 - 10/2008
3
Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 05/2014
3
Residual Neoplasm
01/2022 - 07/2015
3
Philadelphia Chromosome
02/2021 - 06/2015
3
Carcinogenesis
12/2019 - 01/2015
3
Breast Neoplasms (Breast Cancer)
05/2016 - 10/2015
3
Chromosome Aberrations (Chromosome Abnormalities)
04/2016 - 10/2009
3
Adenocarcinoma
06/2015 - 01/2009
3
Nasopharyngeal Carcinoma
12/2013 - 05/2008
2
Hypoalbuminemia
02/2022 - 01/2020
2
Hyperlysinemias (Hyperlysinemia)
01/2022 - 01/2019
2
Neutropenia
01/2022 - 11/2020
2
Febrile Neutropenia
01/2022 - 11/2020
2
Hematologic Diseases (Blood Diseases)
09/2021 - 04/2016
2
Carcinoma (Carcinomatosis)
01/2019 - 01/2015
2
Neoplasm Metastasis (Metastasis)
10/2018 - 03/2014
2
Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
06/2017 - 12/2013
2
Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2017 - 02/2012
2
Circulating Neoplastic Cells
06/2014 - 04/2013
2
Head and Neck Neoplasms (Head and Neck Cancer)
04/2009 - 09/2005
2
Stomach Neoplasms (Stomach Cancer)
03/2009 - 01/2009
1
Anemia
02/2022
1
Hyponatremia
01/2022
1
Leukopenia
01/2022
1
Hypoxia (Hypoxemia)
01/2022
1
Nervous System Diseases (Neurological Disorders)
01/2022
Drug/Important Bio-Agent (IBA)
14
Cisplatin (Platino)
FDA Link
Generic
10/2021 - 09/2005
11
Rituximab (Mabthera)
FDA Link
04/2022 - 09/2012
8
Doxorubicin (Adriamycin)
FDA Link
Generic
03/2020 - 07/2009
7
Fluorouracil (Carac)
FDA Link
Generic
10/2021 - 01/2009
6
Cyclosporine (Ciclosporin)
FDA Link
Generic
01/2021 - 02/2014
6
Proteins (Proteins, Gene)
FDA Link
12/2020 - 10/2009
5
Tyrosine Kinase Inhibitors
IBA
01/2022 - 06/2015
5
DNA (Deoxyribonucleic Acid)
IBA
01/2022 - 02/2015
5
Biological Products
IBA
09/2021 - 04/2009
5
Anthracyclines
IBA
03/2020 - 05/2016
5
Cyclophosphamide (Cytoxan)
FDA Link
Generic
02/2020 - 07/2009
4
Etoposide (VP 16)
FDA Link
Generic
07/2021 - 04/2014
4
Biomarkers (Surrogate Marker)
IBA
01/2020 - 04/2013
4
Gemcitabine
FDA Link
01/2019 - 09/2005
4
Vincristine (Oncovin)
FDA Link
Generic
05/2016 - 07/2009
4
Prednisone (Sone)
FDA Link
Generic
05/2016 - 07/2009
3
Carboplatin (JM8)
FDA Link
Generic
02/2022 - 04/2014
3
ErbB Receptors (EGF Receptor)
IBA
01/2022 - 01/2019
3
Peptides (Polypeptides)
IBA
11/2021 - 06/2013
3
Dexamethasone (Maxidex)
FDA Link
Generic
07/2021 - 02/2012
3
Ifosfamide
FDA Link
Generic
07/2021 - 04/2014
3
Afatinib
IBA
01/2021 - 01/2019
3
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
11/2020 - 02/2014
3
Platinum
IBA
10/2020 - 08/2015
3
Keratins (Keratin)
IBA
01/2020 - 04/2013
3
Antilymphocyte Serum (Anti-Thymocyte Globulin)
IBA
10/2019 - 02/2014
3
Hemoglobins (Hemoglobin)
IBA
02/2019 - 12/2014
2
Cetuximab (Erbitux)
FDA Link
10/2021 - 08/2015
2
Asparaginase (Elspar)
FDA Link
07/2021 - 03/2014
2
Imatinib Mesylate (Gleevec)
FDA Link
03/2021 - 08/2015
2
Therapeutic Uses
IBA
02/2021 - 10/2014
2
Pharmaceutical Preparations
IBA
03/2020 - 04/2011
2
Fibrinogen (Factor I)
FDA Link
01/2020 - 01/2019
2
Oxidoreductases (Dehydrogenase)
IBA
01/2019 - 01/2015
2
Cytarabine (Cytosar-U)
FDA Link
Generic
01/2019 - 01/2018
2
Docetaxel (Taxotere)
FDA Link
06/2017 - 01/2009
2
Epirubicin (Ellence)
FDA Link
Generic
05/2016 - 03/2009
2
MicroRNAs (MicroRNA)
IBA
12/2015 - 10/2015
2
polyacrylamide
IBA
08/2015 - 10/2009
2
Stem Cell Factor
IBA
09/2013 - 04/2011
1
Immune Checkpoint Inhibitors
IBA
02/2022
1
130-nm albumin-bound paclitaxel
IBA
02/2022
1
sintilimab
IBA
02/2022
1
osimertinib
IBA
01/2022
1
Aspartate Aminotransferases (Aspartate Transaminase)
IBA
01/2022
1
saccharopine
IBA
01/2022
Therapy/Procedure
31
Drug Therapy (Chemotherapy)
02/2022 - 09/2005
20
Therapeutics
09/2021 - 05/2010
8
Radiotherapy
04/2022 - 02/2007
5
Induction Chemotherapy
01/2021 - 01/2008
3
Neoadjuvant Therapy
02/2022 - 05/2010
3
Transplantation
01/2021 - 01/2015
3
Salvage Therapy
01/2021 - 01/2008
2
Chemoradiotherapy
07/2021 - 06/2017
2
VAP-cyclo protocol
01/2017 - 12/2014
2
Ligation
04/2016 - 01/2016
2
Combination Drug Therapy (Combination Chemotherapy)
03/2009 - 09/2005
1
Operative Surgical Procedures
02/2022